Sequence Analysis and Homology Modeling of NF2 Protein

Authors

  • Vinod P. Sinoorkar  Walchand Centre for Biotechnology, Walchand College of Arts and Science, Solapur, Maharashtra, India
  • Pratiksha S. Thakurdas  Walchand-Hirachand Marg, Ashok chowk, Solapur, Maharashtra, India

DOI:

https://doi.org//10.32628/IJSRST196159

Keywords:

Insulin deficiency, Hippo signaling pathway, β-cell apoptosis, NF2 protein, Merlin, Neurofibromatosis.

Abstract

Diabetes is diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. In India more than 62 million individuals currently diagnosed with the diabetes. Diabetes is resulting from insulin deficiency or pancreatic cells become insulin resistant. Pancreatic cell (β-cell) death by apoptosis is one of main reason which results in diabetic condition in patients. Neurofibromatosis 2 is involved is β-cell death. Neurofibromatosis 2 (NF2/Merlin) is a tumor suppressor protein, which belongs to the ezrin–radixin–moesin family of actin-binding proteins and regulates the Hippo signaling pathway in mammals and also involved in the regulation of cell proliferation and apoptosis. Merlin regulates the Hippo signaling pathway by controlling the Hippo kinases cassettes MST1/2 and LATS1/2. Therefore, targeting β-cell apoptosis and dysfunction can be a therapeutic approach for the treatment of diabetes. Hence our present investigation focus mainly to understand the detailed molecular features of NF2 by its protein sequence annotation by implementing tools and techniques of Bioinformatics.

References

  1. Calcutt NA, Cooper ME, Kern TS, et al. Therapies for hyperglycemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov. 2009; 8(5):417-429.
  2. Joshi SR, Parikh RM. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007; 55:323-4.
  3. Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524-31.
  4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(3):1047-53.
  5. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004; 328:750-754.
  6. Yu J, Zheng Y, Dong J, et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and expanded. Dev Cell. 2010;18(2):288-299.
  7. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
  8. Kurrer MO, Pakala SV, Hanson HL, et al. Beta cell apoptosis in T cell mediated autoimmune diabetes. Proc Natl Acad Sci U S A. 1997; 94 (1):213-218. 3.
  9. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature. 2001;414(6865):792-798. 4.
  10. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003; 52(1):102-110. 5.
  11. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science.2005; 307(5708):380-384.

Downloads

Published

2019-02-28

Issue

Section

Research Articles

How to Cite

[1]
Vinod P. Sinoorkar, Pratiksha S. Thakurdas, " Sequence Analysis and Homology Modeling of NF2 Protein, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 6, Issue 1, pp.373-377, January-February-2019. Available at doi : https://doi.org/10.32628/IJSRST196159